HØJELSE SMÅDYRSKLINIK ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.2% 7.3% 5.4% 4.7% 4.4%  
Credit score (0-100)  44 33 40 45 46  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  3,336 3,730 4,338 4,643 5,049  
EBITDA  631 958 941 819 1,056  
EBIT  601 923 822 638 831  
Pre-tax profit (PTP)  590.0 908.0 800.3 639.8 819.6  
Net earnings  460.0 700.9 622.8 499.0 637.7  
Pre-tax profit without non-rec. items  590 908 800 640 820  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  82.0 488 713 782 647  
Shareholders equity total  1,039 925 1,247 1,566 1,404  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,447 2,780 2,751 2,690 2,401  

Net Debt  -1,852 -1,824 -1,538 -1,177 -1,271  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,336 3,730 4,338 4,643 5,049  
Gross profit growth  8.6% 11.8% 16.3% 7.0% 8.8%  
Employees  8 7 7 8 8  
Employee growth %  0.0% -12.5% 0.0% 14.3% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,447 2,780 2,751 2,690 2,401  
Balance sheet change%  69.5% 13.6% -1.0% -2.2% -10.7%  
Added value  631.0 957.6 940.7 756.6 1,056.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -60 372 106 -112 -360  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  18.0% 24.8% 19.0% 13.7% 16.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  30.9% 35.3% 29.5% 23.6% 32.8%  
ROI %  64.6% 79.3% 70.5% 45.0% 55.5%  
ROE %  56.8% 71.4% 57.3% 35.5% 42.9%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  42.5% 33.3% 45.3% 58.2% 58.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -293.5% -190.5% -163.5% -143.7% -120.3%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  1.7 1.1 1.2 1.4 1.4  
Current Ratio  2.0 1.3 1.4 1.7 1.7  
Cash and cash equivalent  1,852.0 1,824.1 1,538.0 1,177.0 1,271.2  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,155.0 510.4 610.2 741.0 703.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  79 137 134 95 132  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  79 137 134 102 132  
EBIT / employee  75 132 117 80 104  
Net earnings / employee  58 100 89 62 80